Literature DB >> 25988783

Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 7: Antibiotic-impregnated shunt systems versus conventional shunts in children: a systematic review and meta-analysis.

Paul Klimo1,2, Clinton J Thompson3, Lissa C Baird4, Ann Marie Flannery5.   

Abstract

OBJECT: The objective of this systematic review and meta-analysis was to answer the following question: Are antibiotic-impregnated shunts (AISs) superior to standard shunts (SSs) at reducing the risk of shunt infection in pediatric patients with hydrocephalus?
METHODS: Both the US National Library of Medicine PubMed/MEDLINE database and the Cochrane Database of Systematic Reviews were queried using MeSH headings and key words relevant to AIS use in children. Abstracts were reviewed, after which studies meeting the inclusion criteria were selected. An evidentiary table was assembled summarizing the studies and the quality of their evidence (Classes I-III). A meta-analysis was conducted using a random-effects model to calculate a cumulative estimate of treatment effect using risk ratio (RR). Heterogeneity was assessed using the chi-square and I(2) statistics. Based on the quality of the literature and the result of the meta-analysis, a recommendation was rendered (Level I, II, or III).
RESULTS: Six studies, all Class III, met our inclusion criteria. All but one study focused on a retrospective cohort and all but one were conducted at a single institution. Four of the studies failed to demonstrate a lowered infection rate with the use of an AIS. However, when the data from individual studies were pooled together, the infection rate in the AIS group was 5.5% compared with 8.6% in the SS group. Using a random-effects model, the cumulative RR was 0.51 (95% CI 0.29-0.89, p < 0.001), indicating that a shunt infection was 1.96 times more likely in patients who received an SS.
CONCLUSIONS: We recommend AIS tubing because of the associated lower risk of shunt infection compared to the use of conventional silicone hardware (quality of evidence: Class III; strength of recommendation: Level III). RECOMMENDATION: Antibiotic-impregnated shunt (AIS) tubing may be associated with a lower risk of shunt infection compared with conventional silicone hardware and thus is an option for children who require placement of a shunt. STRENGTH OF RECOMMENDATION: Level III, unclear degree of clinical certainty.

Entities:  

Keywords:  AANS = American Association of Neurological Surgeons; AIS = antibiotic-impregnated shunt; CNS = Congress of Neurological Surgeons; RR = risk ratio; SS = standard shunt; antibiotic-impregnated shunt; cerebrospinal fluid; hydrocephalus; infection; meta-analysis; pediatric patient; practice guidelines; shunt

Mesh:

Substances:

Year:  2014        PMID: 25988783     DOI: 10.3171/2014.7.PEDS14327

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  6 in total

Review 1.  Cerebrospinal Fluid Shunting Complications in Children.

Authors:  Brian W Hanak; Robert H Bonow; Carolyn A Harris; Samuel R Browd
Journal:  Pediatr Neurosurg       Date:  2017-03-02       Impact factor: 1.162

2.  Topical instillation of vancomycin lowers the rate of CSF shunt infections in children.

Authors:  M Krause; C V Mahr; S Schob; U Nestler; R Wachowiak
Journal:  Childs Nerv Syst       Date:  2019-05-20       Impact factor: 1.475

3.  Evaluation of an in vivo model for ventricular shunt infection: a pilot study using a novel antimicrobial-loaded polymer.

Authors:  Rajiv R Iyer; Noah Gorelick; Karen Carroll; Ari M Blitz; Sarah Beck; Caroline M Garrett; Audrey Monroe; Betty Tyler; Sean T Zuckerman; Jeffrey R Capadona; Horst A von Recum; Mark G Luciano
Journal:  J Neurosurg       Date:  2018-08-03       Impact factor: 5.115

4.  Patient and Treatment Characteristics by Infecting Organism in Cerebrospinal Fluid Shunt Infection.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis N Shannon; Mandeep Tamber; John C Wellons Iii; William E Whitehead; Nicole Mayer-Hamblett
Journal:  J Pediatric Infect Dis Soc       Date:  2019-07-01       Impact factor: 3.164

5.  Topical vancomycin reduces the cerebrospinal fluid shunt infection rate: A retrospective cohort study.

Authors:  Erik J van Lindert; Martine van Bilsen; Michiel van der Flier; Eva Kolwijck; Hans Delye; Jaap Ten Oever
Journal:  PLoS One       Date:  2018-01-09       Impact factor: 3.240

6.  Risk factors for pediatric surgical site infection following neurosurgical procedures for hydrocephalus: a retrospective single-center cohort study.

Authors:  Thomas J Sandora; Koichi Yuki; Miho Shibamura-Fujiogi; Jennifer Ormsby; Mark Breibart; Benjamin Warf; Gregory P Priebe; Sulpicio G Soriano
Journal:  BMC Anesthesiol       Date:  2021-04-21       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.